Technological advancements for the development of stem cell-based models for hepatotoxicity testing

Area of Science:

• Stem cell biology
• Hepatocyte differentiation
• Toxicology in vitro

Background:

• Stem cells possess self-renewal and differentiation capabilities, making them a potential source for hepatocyte-like cells (HLCs) in toxicological studies.
• Current in vitro models using stem cell-derived HLCs exhibit limited hepatic functionality compared to primary human hepatocytes.
• Traditional 2D culture systems fail to replicate the native liver microenvironment, hindering optimal stem cell differentiation.

Purpose of the Study:

• To review advanced cell culture systems for stem cell-based hepatocyte-like cell generation.
• To evaluate novel methodologies for improving stem cell differentiation towards functional HLCs.
• To highlight the application of these systems in hepatotoxicity testing for accurate xenobiotic evaluation.

Main Methods:

• Review of scaffold-free and scaffold-based 3D cell culture technologies.
• Analysis of microfluidic systems for stem cell culture and hepatic differentiation.
• Focus on systems mimicking the in vivo liver microenvironment.

Main Results:

• Advanced 3D and microfluidic culture systems demonstrate improved hepatic functionality of stem cell-derived HLCs.
• These novel systems better replicate the physiological conditions of the human liver.
• Enhanced differentiation leads to more accurate in vitro models for hepatotoxicity testing.

Conclusions:

• Emerging 3D and microfluidic technologies offer superior platforms for stem cell hepatic differentiation.
• These advanced culture systems enhance the reliability of in vitro hepatotoxicity testing.
• Stem cell-based hepatic models utilizing these technologies promise accurate xenobiotic evaluation.